Two Sigma Investments’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $196K | Buy |
+17,792
| New | +$196K | ﹤0.01% | 2873 |
|
|
2024
Q3 | – | Sell |
-49,523
| Closed | -$420K | – | 3256 |
|
|
2024
Q2 | $420K | Buy |
+49,523
| New | +$420K | ﹤0.01% | 2369 |
|
|
2024
Q1 | – | Sell |
-38,939
| Closed | -$438K | – | 3292 |
|
|
2023
Q4 | $438K | Buy |
+38,939
| New | +$438K | ﹤0.01% | 2452 |
|
|
2023
Q3 | – | Sell |
-58,058
| Closed | -$601K | – | 3128 |
|
|
2023
Q2 | $601K | Sell |
58,058
-298,809
| -84% | -$3.09M | ﹤0.01% | 2170 |
|
|
2023
Q1 | $3.87M | Sell |
356,867
-605,959
| -63% | -$6.57M | 0.01% | 975 |
|
|
2022
Q4 | $10.8M | Buy |
962,826
+309,956
| +47% | +$3.48M | 0.03% | 508 |
|
|
2022
Q3 | $6.62M | Buy |
+652,870
| New | +$6.62M | 0.02% | 624 |
|
|
2022
Q2 | – | Sell |
-149,240
| Closed | -$1.43M | – | 2862 |
|
|
2022
Q1 | $1.43M | Buy |
149,240
+114,174
| +326% | +$1.09M | ﹤0.01% | 1476 |
|
|
2021
Q4 | $387K | Buy |
+35,066
| New | +$387K | ﹤0.01% | 2080 |
|
|
2021
Q2 | – | Sell |
-40,962
| Closed | -$836K | – | 2871 |
|
|
2021
Q1 | $836K | Buy |
+40,962
| New | +$836K | ﹤0.01% | 1669 |
|
|
2020
Q4 | – | Sell |
-39,519
| Closed | -$584K | – | 2419 |
|
|
2020
Q3 | $584K | Sell |
39,519
-132,531
| -77% | -$1.96M | ﹤0.01% | 1357 |
|
|
2020
Q2 | $3.61M | Buy |
+172,050
| New | +$3.61M | 0.02% | 662 |
|
|
2018
Q4 | – | Sell |
-15,656
| Closed | -$511K | – | 2422 |
|
|
2018
Q3 | $511K | Buy |
+15,656
| New | +$511K | ﹤0.01% | 1585 |
|
|
2017
Q1 | – | Sell |
-26,931
| Closed | -$859K | – | 2427 |
|
|
2016
Q4 | $859K | Buy |
26,931
+16,299
| +153% | +$520K | ﹤0.01% | 1563 |
|
|
2016
Q3 | $385K | Buy |
+10,632
| New | +$385K | ﹤0.01% | 1697 |
|
|
2015
Q1 | – | Sell |
-46,775
| Closed | -$698K | – | 2372 |
|
|
2014
Q4 | $698K | Buy |
+46,775
| New | +$698K | ﹤0.01% | 1555 |
|